Mechanism of Action of Nitroprusside
Sodium nitroprusside works as a balanced preload-reducing venodilator and afterload-reducing arteriodilator that directly relaxes vascular smooth muscle, causing vasodilation of both peripheral arteries and veins. 1
Primary Mechanism
Sodium nitroprusside functions through the following mechanism:
Direct nitric oxide release: Nitroprusside releases nitric oxide (NO) nonenzymatically through a one-electron reduction that occurs upon exposure to reducing agents and vascular smooth muscle membranes 2
Activation of guanylate cyclase: The released nitric oxide activates guanylate cyclase in vascular smooth muscle cells 3
Cyclic GMP accumulation: This activation results in increased levels of cyclic GMP within the smooth muscle cells 3
Smooth muscle relaxation: The increased cyclic GMP leads to relaxation of vascular smooth muscle, causing vasodilation
Hemodynamic Effects
The vasodilatory action of nitroprusside produces several important hemodynamic effects:
Venous dilation: More pronounced effect on veins than arteries (though less selective than nitroglycerin) 1
- Promotes peripheral pooling of blood
- Decreases venous return to the heart
- Reduces left ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload)
Arterial dilation: 1
- Reduces systemic vascular resistance
- Lowers systolic and mean arterial pressure (afterload)
- Dilates coronary arteries
Pulmonary vasodilation: Also dilates the pulmonary vasculature 4
Pharmacokinetics
- Rapid onset: Hypotensive effect begins within 1-2 minutes of starting an adequate infusion 1
- Short duration: Effect dissipates almost as rapidly after infusion is discontinued 1
- Short half-life: Circulatory half-life of approximately 2 minutes 1
- Metabolism: Rapidly distributed to extracellular space and cleared by intraerythrocytic reaction with hemoglobin 1
Clinical Applications
Nitroprusside is primarily used in:
- Acute hypertension management
- Heart failure treatment (especially with hypertension or severe mitral valve regurgitation) 4
- Controlled hypotension during surgery 5
Important Considerations and Cautions
- Monitoring requirements: Requires close hemodynamic monitoring, often with invasive blood pressure monitoring 4
- Metabolism to cyanide: Nitroprusside is metabolized to cyanmethemoglobin and cyanide ions 1
- Thiocyanate toxicity: Longer infusions can lead to thiocyanate toxicity, particularly in patients with renal insufficiency 4
- Hypotension risk: Has potential for producing marked hypotension and is typically used in intensive care settings 4
Nitroprusside's balanced arterial and venous dilation properties make it particularly effective for rapid blood pressure control and management of heart failure with elevated systemic vascular resistance, though its use requires careful monitoring due to its potent effects and metabolism to potentially toxic byproducts.